Impact on quality of life of alleviating carbohydrate counting for patients with type 1 diabetes using a novel insulin-plus-pramlintide artificial pancreas: a randomized controlled crossover trial

使用新型胰岛素加普兰林肽人工胰腺减轻 1 型糖尿病患者碳水化合物计数对生活质量的影响：一项随机对照交叉试验

• 批准号: 428757
• 负责人: COHEN ELISA
• 金额: $ 1.27万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-12-01 至 2020-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=428757&lang=en
• 关键词: Biomedical; Carbohydrate-Coutning; Clinical Trial; Insulin; Pramlintide; Psychosocial; Qualitative; Quality-Of-Life; Semi-Structured Interviews; Type 1 Diabetes

"Type 1 diabetes is an autoimmune disease that results in the destruction of insulin-producing beta-islet cells in the pancreas, requiring people with Type 1 diabetes to received life-long exogenous supplementation of insulin, either in the form of multip

“1型糖尿病是一种自身免疫性疾病，导致胰腺中产生胰岛素的β-胰岛细胞被破坏，需要1型糖尿病患者终身接受外源性胰岛素补充，无论是以多种形式，还是以多种形式。